Loss Time Life

Rosenstiel professor awarded endowed chair in earth sciences

Retrieved on: 
Friday, May 19, 2023
Aircraft, University, Data science, American Meteorological Society, Loss Time Life, Teaching, National Oceanic and Atmospheric Administration, Cosmology, Research, Category, Cooperative Institute for Marine and Atmospheric Studies, Forecasting, Hurricane Andrew, Computing, Rosenstiel School of Marine and Atmospheric Science, Climate change, Atmospheric science, Risk, Love, Earth, Weather, CORAL, Agriculture, Management, Atmosphere, Earth science

Earlier this month, the Rosenstiel School of Marine, Atmospheric, and Earth Science at the University of Miami awarded the inaugural William R. Middelthon III Endowed Chair in Earth Sciences to Benjamin Kirtman, a professor in the school’s Department of Atmospheric Sciences.

Key Points: 
  • Earlier this month, the Rosenstiel School of Marine, Atmospheric, and Earth Science at the University of Miami awarded the inaugural William R. Middelthon III Endowed Chair in Earth Sciences to Benjamin Kirtman, a professor in the school’s Department of Atmospheric Sciences.
  • “I am honored to have the opportunity to establish this endowed chair," said Middelthon, a longtime supporter of the school’s research and education initiatives.
  • “I am deeply honored to be the first recipient of the William R. Middelthon III Endowed Chair in Earth Sciences,” said Kirtman.
  • The William R. Middelthon III Endowed Chair in Earth Sciences is part of the University’s Centennial Talents initiative, a bold plan to significantly increase the number of endowed positions by 2025 in celebration of the University’s centennial.

OH, CANADA! NEW SEASONS OF CANADIAN ORIGINAL DRAMAS FAMILY LAW AND DEPARTURE RETURN, PLUS NEW UNSCRIPTED SERIES SUPERFAN FEATURING SHANIA TWAIN JOIN GLOBAL AND STACKTV'S SUMMER LINEUP

Retrieved on: 
Monday, May 1, 2023
Giant, Amazon Fire TV, Strategic management, Networking hardware, Nose, Nate Burleson, Fortunate Son, Corus Entertainment, SaskTel, Archie Panjabi, Howard T. Owens, STACKTV, Panic, Bell, CDN, Loss Time Life, Departure, Marriage, Android, LL, IOS, Motive, Critics' Choice Television Award for Best Drama Series, Hollywood North, Genelle Williams, Shaw Direct, Paramount Global, CBS Mornings, Terminal Productivity Executive, Joanne, Water, Ensemble cast, AMA, Starling, Content, Vidéotron, COM, Screen Awards, Paramount Global Content Distribution, Narrows, Originality, Roku, Film industry, Management, Chromecast, Kid, Eastlink, Telus, Cogeco, Corus, Superfan

The wait is over for Family Law Season 2, premiering Monday, May 22 at 8 p.m. ET/PT on Global and STACKTV.

Key Points: 
  • The wait is over for Family Law Season 2, premiering Monday, May 22 at 8 p.m. ET/PT on Global and STACKTV.
  • "With the return of Global Originals Family Law and Departure, these compelling and entertaining series are sure to captivate Canadian audiences once again.
  • And with the addition of Superfan to our summer schedule, we only further add to the star power that Global is best known for."
  • After six months' probation at her father's firm, Abby's getting into the groove of family law –but her marriage is a trainwreck.

Waze to Wealth Implements Tax Optimized Wealth Planning Strategies to Help Silicon Valley Tech Professionals

Retrieved on: 
Tuesday, January 10, 2023
Loss Time Life, Longevity, Silicon, Tax, Knowledge, Disability, Financial adviser

San Jose, California--(Newsfile Corp. - January 10, 2023) - Waze To Wealth, a San Jose, California-based financial services team, is implementing holistic tax-advantaged wealth planning strategies to assist Silicon Valley tech professionals in meeting their financial goals.

Key Points: 
  • San Jose, California--(Newsfile Corp. - January 10, 2023) - Waze To Wealth, a San Jose, California-based financial services team, is implementing holistic tax-advantaged wealth planning strategies to assist Silicon Valley tech professionals in meeting their financial goals.
  • The company includes Financial Professional Tom Southard, a former technology executive who now supports tech professionals by troubleshooting their finances as a licensed professional and Certified Retirement Counselor.
  • "A worry-free retirement requires thoughtful planning and execution," said Tom Southard.
  • Waze to Wealth takes a broad view of their client's financial situation as they put together a tailored plan for a client's future.

Hexion Completes Capacity Expansion for its ArmorBuilt™ Wildfire Shield Product

Retrieved on: 
Tuesday, January 10, 2023
Science, Natural Disasters, Other Science, Research, Environment, Other Manufacturing, Chemicals, Plastics, Manufacturing, San Francisco Chronicle, California Department, Partnership, California Department of Forestry and Fire Protection, Pacific Gas and Electric Company, Certification, Quality management system, Forestry, Material, Loss Time Life, The Electric Company, Wildfire, National Science Foundation Network, WIRC, CAL, ISO9001, National Science Foundation, Life, Fire protection, SJSU, Senior, Electrical cable, Oil, Hexion

Hexion has completed the expansion of its Missoula, Montana site in support of its ArmorBuilt Wildfire Shield product.

Key Points: 
  • Hexion has completed the expansion of its Missoula, Montana site in support of its ArmorBuilt Wildfire Shield product.
  • Hexion’s ArmorBuilt Fire Protection product offers a durable, fire mitigation safeguard for securing critical infrastructure or other building materials.
  • ArmorBuilt Wildfire Shield is a smart material triggered by heat to form an insulation layer and protect the underlying pole and related infrastructure.
  • “For more than a century, Hexion has delivered sustainable product innovations and technologies that enhance everyday life.

Precision Cancer Therapeutics Markets, 2022 - Focus on Monoclonal Antibodies, Kinase Inhibitors, Angiogenesis Inhibitors, Proteasome Inhibitors, & CAR-T therapies - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 27, 2022
Health, Oncology, Cancer, Stomach, Therapy, Lung, PI3K, CDK, Breast, Histone deacetylase inhibitor, Prostate, Loss Time Life, Patient, PARP, Liver, Medical device, Pharmaceutical industry, Medical imaging

The "Precision Cancer Therapeutics, 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Precision Cancer Therapeutics, 2022" report has been added to ResearchAndMarkets.com's offering.
  • Precision Cancer Therapeutics, 2022 focuses on the expanding area of precision cancer therapies and includes current products available and discusses some of the most exciting developments in progress.
  • Today, advanced precision cancer therapies are available, and more are being developed each year.
  • This report covers precision cancer therapies that do at least one of the following:
    Carry toxins to the cancer cells to kill them, but not normal cells
    This report Precision Cancer Therapeutics, 2022 specifically focuses on five leading segments of precision therapies:

EQS-News: Amerigo Announces Q3-2022 Results & Quarterly Dividend

Retrieved on: 
Thursday, November 3, 2022
DET, Retirement, Risk, Metal, Cauquenes, Water, News, LME, Industry, COVID-19, OXO-biodegradation, MVC, Transport, Contract, Government, Personal injury, Compliance, Molybdenum, Company, Copper, Loss Time Life, Engineering, Mining, Codelco, Renewable energy, Audit, Iron ore, Oil, Coffee, Risk management, Life insurance, Security (finance), Practice of law, Health insurance, Construction

This news release contains certain forward-looking information and statements as defined in applicable securities laws (collectively referred to as "forward-looking statements").

Key Points: 
  • This news release contains certain forward-looking information and statements as defined in applicable securities laws (collectively referred to as "forward-looking statements").
  • Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release.
  • Other events or circumstances could cause our actual results to differ materially from those estimated or projected and expressed in, or implied by, our forward-looking statements.
  • You should also carefully consider the matters discussed under Risk Factors in the Company`s Annual Information Form.

23 Companies Dominate Cancer Therapeutics, Kalorama Information Report Finds

Retrieved on: 
Monday, October 31, 2022
Antibody, Prostate, Therapy, Cancer, Liver, Patient, Lung, Industry, Macrophage, Antigen, Loss Time Life, Cell, Information, Recurrence, Drug, Breast, Stomach, Pharmaceutical industry, Vaccine

ARLINGTON, Va., Oct. 31, 2022 /PRNewswire-PRWeb/ -- Precision Cancer Therapeutics, 2022, a new report from medical market researcher Kalorama Information, takes a look at the business of cancer therapeutics, with a particular focus on 23 companies.

Key Points: 
  • Precision Cancer Therapeutics, 2022 focuses on the expanding area of precision cancer therapies and includes current products available and discusses some of the most exciting developments in progress.
  • ARLINGTON, Va., Oct. 31, 2022 /PRNewswire-PRWeb/ -- Precision Cancer Therapeutics, 2022 , a new report from medical market researcher Kalorama Information, takes a look at the business of cancer therapeutics, with a particular focus on 23 companies.
  • Kalorama Information has watched the cancer treatment market evolve over the past two decades and evaluated the impact new technologies are making on the market.
  • In Kalorama's report the focus is on these 23 companies that have a large presence in the cancer therapeutic market and can be considered specialists and/or innovators.

EQS-News: Amerigo Reports Q3-2022 Production Results

Retrieved on: 
Tuesday, October 11, 2022
Online, Aurora, News, International, Molybdenum, Metal, Loss Time Life, Government, IFRS, Efficiency, Transport, TSX, MVC, OXO-biodegradation, Contract, Codelco, Retirement, Company, Compliance, Industry, Personal injury, Cauquenes, International Financial Reporting Standards, Water, Copper, COVID-19, Engineering, Mining, SEDAR, Risk, Renewable energy, Medical device, Life insurance, Audit, Iron ore, Oil, Coffee, Risk management, Online gambling, Security (finance), Practice of law, Health insurance, Construction, Amerigo

Release of Q3-2022 results on November 2, 2022

Key Points: 
  • Release of Q3-2022 results on November 2, 2022
    Amerigo will release Q3-2022 financial results at market open on Wednesday, November 2, 2022.
  • Amerigo Resources Ltd. is an innovative copper producer with a long-term relationship with Corporacin Nacional del Cobre de Chile (Codelco), the worlds largest copper producer.
  • Future production levels and cost estimates assume there are no adverse mining or other events which significantly affect budgeted production levels.
  • Other events or circumstances could cause our actual results to differ materially from those estimated or projected and expressed in, or implied by, our forward-looking statements.

The Worldwide Military Wearables Industry is Expected to Reach $3.4 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 22, 2022
Technology, Defense, Other Defense, Wearables, Mobile Technology, Adoption, Augmented reality, Navy, Risk, Loss Time Life, Army, Headgear, Growth, Night vision, USD, Investment, Air force, Anxiety, VR, Virtual reality, Depression, CAGR, Airline, Technology

The global military wearables market is projected to grow from USD 3.1 billion in 2022 to USD 3.4 billion by 2027, at a CAGR of 1.8% from 2022 to 2027.

Key Points: 
  • The global military wearables market is projected to grow from USD 3.1 billion in 2022 to USD 3.4 billion by 2027, at a CAGR of 1.8% from 2022 to 2027.
  • The military wearables market is envisioned to grow on account of the soldier modernization programs undertaken by several nations across the globe.
  • Based on technology, the video & surveillance segment is projected to lead the military wearables market during the forecast period.
  • The Military Wearables industry has been studied for North America, Europe, Asia-Pacific, Middle East, and Rest of the World.

Revitalist and Wake Network Enter Joint Venture Offering National and International Access to Psychedelics for Veterans

Retrieved on: 
Tuesday, September 13, 2022
Neurology, Defense, Pharmaceutical, Alternative Medicine, Health, Mental Health, Veterans, Other Health, Psilocybin, National, Therapy, Loss Time Life, FSE, Retreat, CALM, Wellness, CEO, CSE, Veteran, Anxiety, Meta-analysis, Research, Medicine, Suicide, PTSD, Depression, Pharmaceutical industry, Ketamine

Psilocybin and Ketamine have been shown to improve depression, PTSD, suicidality, anxiety, and other conditions that cause loss of life for many of our veterans.

Key Points: 
  • Psilocybin and Ketamine have been shown to improve depression, PTSD, suicidality, anxiety, and other conditions that cause loss of life for many of our veterans.
  • A meta-analysis from the National Institutes of Health reports, approximately 5 million deaths worldwide are attributable to mood and anxiety disorders each year.
  • This eight day retreat takes place at the Veterans Healing Farm in North Carolina, followed by a five day psilocybin retreat in Jamaica.
  • Each clinic enables access to psychedelic medicine, vitamin infusions and other lifestyle optimization services provided by medical and behavioral professionals.